Sanofi SA (NASDAQ:SNY)
| 52.44 Delayed Data As of Sep 18 |  +0.37 / +0.71%Today’s Change | 37.62 Today|||52-Week Range 55.00 | +4.46% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | 4.7B | 5.2B | 9.5B | 5.1B | |
| Depreciation | 4.7B | 3.6B | 3.5B | 4.1B | ||
| Total Other Cash Flow | 612.5M | -123.6M | -3.8B | -226.5M | ||
| Funds From Operations | 8.7B | 8.1B | 8.2B | 8.1B | ||
| Funds From/For Other Operating Expenses | -1.2B | -913.9M | -166.9M | 1.5B | ||
| Net Cash Flow - Operating Activities | 9.8B | 9.0B | 8.3B | 6.5B | ||
| Investing | Increase In Investments | -156.7M | -229.6M | -181.6M | -15.3B | |
| Capital Expenditures | -3.1B | -2.3B | -2.2B | -2.3B | ||
| Fixed Asset Disposal | 232.9M | 230.7M | 603.4M | 2.6B | ||
| Net Assets From Acquisitions | -251.6M | -482.3M | -1.3B | -90.8M | ||
| Other Investing - Uses | -368.6M | -142.4M | -183.9M | -75.5M | ||
| Other Investing - Sources | 0.00 | 0.00 | 4.0B | 0.00 | ||
| Net Cash Flow Investing | -3.6B | -2.9B | 679.0M | -15.3B | ||
| Financing | Short Term Borrowings | -219.6M | 106.0M | 33.8M | -198.2M | |
| Long Term Borrowings | 2.5B | 5.3B | 46.2M | 11.4B | ||
| Long Term Debt Reduction | -781.4M | -2.8B | -2.7B | -928.5M | ||
| Net Proceeds Stock Sale | 633.5M | 337.8M | 359.8M | 208.8M | ||
| Common Preferred Redeemed | -2.0B | -3.2B | -2.4B | -1.3B | ||
| Common Dividends | -4.1B | -4.1B | -4.2B | -4.5B | ||
| Cash Dividends Paid - Total | -4.1B | -4.1B | -4.2B | -4.5B | ||
| Other Sources - Financing | 0.00 | 121.4M | -- | -- | ||
| Other Uses - Financing | 38.6M | 23.2M | 16.9M | 16.5M | ||
| Net Cash Flow - Financing | -4.0B | -4.4B | -8.9B | 4.7B | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -256.0M | -111.5M | -83.5M | 1.2M | |
| Net Change In Cash | 2.3B | 1.7B | 130.8M | -4.0B | ||
